Effects of ICS treatment compared with placebo were estimated by analysing changes in lung function , hyperresponsiveness , and inflammatory cells in sputum and bronchial biopsies during short-term ( 0-6 months ) and long-term ( 6-30 months ) treatment using multiple regression analyses .